Bioanalytical Testing and Quantification of Compound Levels

The contract requires the performance of bioanalytical quantification of the compound NCGC00592266 in plasma and tissue samples using validated liquid chromatography-tandem mass spectrometry methods. The objective is to generate precise concentration-time data to support pharmacokinetic analysis, ensuring accurate characterization of the compound’s absorption, distribution, metabolism, and elimination in biological matrices. All methods must be fully validated and compliant with industry standards to guarantee data integrity and reproducibility across sample types. The solicitation, posted on August 7, 2026, with a response deadline of August 24, 2026, is classified as a subcontract under NAICS code 541380, which corresponds to scientific research and development services. The issuing agency is the National Institutes of Health under the Department of Health and Human Services, though no specific office location or point of contact is provided. The place of performance details are unspecified, indicating potential flexibility in where the work may be conducted, as long as analytical requirements are met. Participation requires demonstrated expertise in advanced bioanalytical techniques and prior experience with LC-MS/MS-based pharmacokinetic studies.